Terry L. Wahls
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Terry L. Wahls sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Terry L. Wahls: 6 sponsored US clinical trials, 2 recruiting.
Terry L. Wahls sponsors 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Clinically Isolated Syndrome, with 2 trials.
Upper-quartile sponsor footprint
Terry L. Wahls sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
Creating Health Course Study for People With Rheumatological Conditions
NCT07180537
Autoimmune Intervention Mastery Course Study
NCT05057676
Efficacy of Diet on Quality of Life in Multiple Sclerosis
NCT05007483
Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis
NCT04009005
Dietary Approaches to Treat Multiple Sclerosis-Related Fatigue Study
NCT02914964
Wahls Paleo Diet and Progressive Multiple Sclerosis
NCT01915433
Therapeutic Areas
What is open in the Terry L. Wahls pipeline
2 recruiting of 6 indexed (33% open); 2 completed (33%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Clinically Isolated Syndrome (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Terry L. Wahls: open-pipeline peers nationwide
Peers matched on 6 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
Terry L. Wahls sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this Terry L. Wahls page
6 registered trials is a research-attention snapshot, not an endorsement of Terry L. Wahls or any single study.
- 2 of Terry L. Wahls's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Clinically Isolated Syndrome is the condition Terry L. Wahls studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Clinically Isolated Syndrome trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Terry L. Wahls pipeline card: 6 registered trials from official public datasets.Report a data error.